The 21st Annual Congress of International Drug Discovery Science and Technology

2025-02-28T14:23:26+01:0011.2024|

The 21st IDDST (Europe), takes place June 18 - 20, 2025 in Stockholm, Sweden, and will host leading scientists from the academia and outstanding international experts from industry worldwide, to discuss the latest developments in drug discovery and therapy. The program will offer complete updates of recent developments and present the latest results in the remarkable separate tracks. Main idea and target is to stimulate new creative ideas to translate new discoveries into better practice and application.
In session 504 Cardiovascular Diseases Drug R&D Pipelines ...

3rd International Heart Congress 2025

2024-11-19T13:16:57+01:0011.2024|

The congress takes place 2025 in Rome, Italy, from June 5 - 7.

The most important aspect of this congress is bridging science, innovation, and patient care with the focus on heart health.
The scientific sessions bring together experts from the fields of basic research, translational medicine, pharma R&D, and patient care in order to help to improve cardiovascular outcomes.

Cardiology World Conference CARDIO 2024

2024-11-27T11:49:12+01:0011.2024|

The Cardiology World Conference CARDIO 2024 takes place September  5 - 7, 2024, in Madrid, Spain.

The lecture of Thomas Bernd Dschietzig is about treatment of HFpEF and focuses on pre-clinical experiments and results with relaxin-2, explaining the bolus therapy and the signalling portfolio of the native peptide.
Relaxin-2 delivery reverses diastolic dysfunction, arrhythmia susceptibility, inflammation, and excess fibrosis.
...

D-A-C-H-Region Congress “Heart Failure”

2024-11-19T13:19:26+01:0006.2023|

The Heart Failure Congress takes place September  28 – 30, 2023, in Göttingen, Germany. The lectures focus on heart failure treatment options, HFpEF, on electrophysiology, diagnostics, operative and intervention heart failure treatment and additional with a view on several comorbidities. On September 28, the session “Pipeline for the therapy of heart failure” (at 1 pm) [...]

9th International Conference on Relaxin and Related Peptides

2023-06-16T13:57:03+02:0006.2023|

Relaxera is supporting and attending the 9th International Conference on Relaxin and Related Peptides. Featured presenters cover all aspects of basic biology and physiology, plus potential clinical applications of relaxin and related peptides. One of our contributions will be the chairing of the session “Circulatory and Vasculatory Actions".  As well we present new research results [...]

Interview Digital Health TV 2022

2023-01-25T16:57:48+01:0010.2022|

Two  interviews with the Bavarian Health Management GmbH in Germany  about "Relaxin and Heart Failure" and "Relaxin and Transplantation Medicine". Prof. Andreas Grün is interviewing Prof. Dr. Thomas B. Dschietzig, CEO Relaxera. (in German language) interview 1 - Relaxin and heart failure; get the summary here. interview 2 - Relaxin and transplantation medicine; get the [...]

Presentation at European Society of Cardiology (ESC) Congress 2022 in Barcelona

2022-12-16T17:53:58+01:0007.2022|

First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the ESC congress 2022 in Barcelona by Prof. Dr. Guy Salama in the session "HFpEF and HFmrEF: what’s new in treatment" - “The therapeutic potential of relaxin for heart failure with preserved ejection fraction” You will learn about relaxin-2-[...]

© Copyright , Relaxera Pharmazeutische Gesellschaft mbH & Co. KG
Go to Top